The role of breast stem cells in early stages of breast carcinogenesis - breast tissue is dynamic and undergoes significant structural changes throughout a woman's life

Active Grant Awarded

Award ID
R01CA313427
Recipient
Awarding agency
Obligated
$746,412

Award facts

Assistance listing
93.393 Cancer Cause and Prevention Research
Completion date 8% complete
Place of performance
Gainesville, FL 32611, USA

Award details come from USAspending.gov.

About this award

The National Cancer Institute, within the Department of Health and Human Services National Institutes of Health, awarded the University of Florida Division of Sponsored Research $746,412 on July 6, 2026, under Cancer Cause and Prevention Research (CFDA 93.393), for Grant R01CA313427, a study of breast stem cells in early breast carcinogenesis. The period of performance runs through June 30, 2031, with work performed in Gainesville, Florida.

The project will characterize high-risk breast stem cell lineages defined by co-stained marker combinations and test their associations with three outcomes: mammographic percent density and AI-based mammographic features in histologically normal tissue (N=1,290); subsequent breast cancer risk among women with a previous benign biopsy (444 cases/1,003 controls); and hormone-related factors, including oral contraceptives, menopausal hormone therapy, alcohol use, body mass index, and reproductive factors (N=1,834). Data, samples, and mammograms come from the Nurses' Health Study, NHS II, Washington University's Women's Health Repository, and a separate collection from healthy women.

Weill Medical College of Cornell University is the sub-recipient under a sub-award dated October 22, 2026. Its site principal investigator directs administrative and data management for the Nurses' Health Study data, coordinates tissue sample selection with repository staff, harmonizes biomarker and risk-factor data for analysis, and hires a postdoctoral fellow. H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. is the second sub-recipient, under a sub-award dated October 8, 2026. Its work covers automated breast cancer risk-feature generation and automated percent breast density measurements at Moffitt Cancer Center, along with quality assurance on image data received from the study sites.

Description

The breast tissue architecture is maintained by a population of stem cells with self-renewal capacity which are essential for tissue repair and remodeling. Recently, the role of stem cells in breast carcinogenesis has been recognized as a high priority for translational breast cancer (BCA) research. The stem cell hypothesis of breast carcinogenesis suggests that breast cancer development might be directly related to the size of the stem cell pool and its mitotic activity. Further, in the mammary gland, stem cells are the only cell subpopulation that has capacity to accumulate all the oncogenic alterations. This project will fill gaps in our understanding of the role of stem cells in the early stages of breast carcinogenesis and their interplay with BCA risk factors by focusing on CO-stained stem cell marker combinations that are reflective of high-risk stem cell lineages. Specifically, we will explore: 1) the associations of high-risk stem cell lineages (CD44+/CD24-/low, epcam-/low/CD49FHIGH and ALDH1A1HIGH/CD44+/CD133+) in histologically normal breast tissue with mammographic percent density and AI- based mammographic features (N=1,290); 2) the associations of high-risk stem cell lineages with subsequent BCA risk in women with a previous benign biopsy (444 cases/1,003 controls); and 3) the associations of hormone-related factors (oral contraceptives, menopausal hormone therapy, alcohol use, body mass index, weight gain since age 18, and reproductive factors) with high-risk stem cell lineages (N=1,834). We will use prospectively collected data/samples/ mammograms from cancer-free women with benign breast disease (BBD) within the nurses' health study (NHS), NHS II, washington university's women's health repository (WHR), and a unique collection of data/samples/mammograms from healthy women in the komen tissue bank, with the final study population representative of US demographics. Stem cell markers will be stained on study tissue microarrays (specifically constructed from histologically normal breast tissue regions) with commercially available antibodies using multiplex immunofluorescence, and the staining results will be evaluated with automated image analysis. We propose a highly novel investigation that will comprehensively examine the role of stem cell markers in breast carcinogenesis. The study aims to shed light on molecular pathways behind the observed associations of risk factors with BCA risk as well as to identify markers that could advance future risk prediction in a large segment of high-risk women undergoing routine breast biopsies and those with high-risk mammographic features. This proposal could pave the way for novel personalized breast cancer prevention and surveillance strategies. As stem cell activity is potentially modifiable via a variety of targeted therapies, the findings could translate into stem cell -directed pharmaceutical interventions aimed at BCA risk reduction in high-risk women with BBD and/or high mammographic breast density in whom novel prevention strategies are urgently needed.

Subawards

Subrecipient Amount Awarded
Weill Medical College Of Cornell University Rulla Tamimi, ScD, MPI and Site Principal Investigator, has worked with the Nurses' Health Studies (NHS) for over 15 years. She is very familiar with the… $144,489
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. Dr. Heine is a Senior Member in the Cancer Epidemiology Department. Dr. Heine authored numerous manuscripts addressing statistical methods for analyzing digital… $52,708

Quick answers

Who received award R01CA313427?

R01CA313427 was awarded to University Of Florida by National Cancer Institute (National Institutes of Health) on July 6, 2026.

How much is award R01CA313427 worth?

$746,412 has been obligated on R01CA313427.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award